Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Shire LLC et al v. Abhai LLC
Case Number:
1:15-cv-13909
Court:
Nature of Suit:
Judge:
Firms
-
July 11, 2018
Shire Gets $1M Less In Atty Fees Than Sought In Drug Win
A Massachusetts federal judge awarded $1.5 million in attorneys' fees to Shire PLC on Wednesday, more than $1 million less than corporate counsel originally sought for prevailing in a patent bench trial that included a five-month intermission after the company's opponent unveiled corrected drug tests central to the case.
-
May 09, 2018
Shire Defends $2.4M Fee Request In Adderall Generic Row
Adderall XR maker Shire PLC defended a request for nearly $2.4 million in attorneys' fees on Wednesday, saying the bill was due solely to misconduct by the generic competitor it trounced in a patent bench trial last year.
-
May 04, 2018
Shire's $2.4M Fee Bid In Adderall Row Too High, Rival Says
Shire PLC is trying to overbill a generic competitor with a $2.38 million fee request after winning a patent infringement suit over its popular hyperactivity treatment Adderall XR, Shire's competitor told a Massachusetts federal judge late Thursday.
-
April 19, 2018
Judge Unseals $2 Million Fee Request In Adderall Patent Suit
A Massachusetts federal judge on Thursday unsealed a request from Shire PLC to bill a generic competitor $2 million after winning a patent infringement suit over its hit hyperactivity treatment Adderall XR.
-
March 22, 2018
Shire Wins Adderall Suit While Loser Gets Sanction Request
Shire PLC prevailed on patent claims Thursday over a small pharmaceutical company that withheld data until midtrial showing how closely its generic product resembled hit hyperactivity treatment Adderall XR, misconduct that led a Massachusetts federal judge to take the unusual action of asking regulators to sanction the company.
-
October 18, 2017
Generic-Drug Maker Faces Sanctions As Adderall Trial Closes
A Boston federal judge indicated Wednesday that he's inclined to impose financial sanctions against a small pharmaceutical company that lost drug-comparison data amid Shire LLC's infringement suit over patents for time-release formulas in its blockbuster hyperactivity treatment Adderall XR.